Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) EBT Margin (2019 - 2023)

Historic EBT Margin for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to 313.27%.

  • ADC Therapeutics' EBT Margin fell 2460300.0% to 313.27% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.23%, marking a year-over-year increase of 957800.0%. This contributed to the annual value of 73.68% for FY2022, which is 728600.0% down from last year.
  • ADC Therapeutics' EBT Margin amounted to 313.27% in Q3 2023, which was down 2460300.0% from 273.3% recorded in Q2 2023.
  • ADC Therapeutics' EBT Margin's 5-year high stood at 0.0% during Q4 2022, with a 5-year trough of 14021379.31% in Q3 2020.
  • In the last 5 years, ADC Therapeutics' EBT Margin had a median value of 377.77% in 2022 and averaged 938271.04%.
  • In the last 5 years, ADC Therapeutics' EBT Margin crashed by 2000000000bps in 2020 and then surged by 2000000000bps in 2021.
  • Quarter analysis of 5 years shows ADC Therapeutics' EBT Margin stood at 15842.34% in 2019, then plummeted by -88406bps to 14021379.31% in 2020, then soared by 100bps to 331.29% in 2021, then surged by 100bps to 0.0% in 2022, then plummeted by -1082987170bps to 313.27% in 2023.
  • Its EBT Margin was 313.27% in Q3 2023, compared to 273.3% in Q2 2023 and 314.28% in Q1 2023.